Nociceptive Pain: Medical and Patient Perspectives

In this episode, Michael Sprintz, DO, DFASAM, and Tia, a patient and advocate, talk about their experiences with opioid use disorder, pain, and the road to recovery. This podcast aims to differentiate opioid dependency from opioid use disorder, decrease the stigma of opioid misuse, and encourage those affected by it to seek treatment. The informative discussion includes first-hand perspectives of developing opioid dependency, a call to action for both healthcare professionals and patients to remember that addiction is a biological disorder and the importance of open communication to build a strong support system in the face of addiction. 

Listen as  Samantha Catanzano, PharmD, BCPP; Andrew Friedman, MD; and Mark Queralt, MD, answer the most pressing questions from 2 live webinars covering nonpharmacologic, nonopioid, and opioid pharmacologic options for pain management. These webinars are part of the 2022-2023 Opioid REMS Education Initiative and are titled, “Managing Pain: A Focus on Nonpharmacologic and Nonopioid Approaches” and “Managing Pain: A Focus on Opioid Analgesic Approaches.”

Presenters:

Samantha Catanzano, PharmD, BCPP
Clinical Assistant Professor
Division of Pharmacy Practice
The University of Texas at Austin  
College of Pharmacy
Board-Certified Psychiatric Pharmacist
Integrated Behavioral Health Department
Austin, Texas

Andrew Friedman, MD
Section Head, Physical Medicine and Rehabilitation
Virginia Mason Medical Center
Clinical Assistant Professor
University of Washington
Seattle, Washington

Mark Queralt, MD
Assistant Professor
Director of the Musculoskeletal Institute
Back and Neck Pain Clinical Director
University of Texas Health Austin
Austin, Texas

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi

Listen as Amanda Zimmerman, PA-C, and Chin Hwa (Gina) Dahlem, PhD, FNP-C, answer audience questions that were submitted at the June 2023 webinar titled, “Safe and Smart: Teaching Patients About Safe Opioid Practices.” Their answers cover topics including how to conduct a pill count and cost concerns regarding naloxone. 

Presenters: 

Chin Hwa (Gina) Dahlem, PhD, FNP-C 
Clinical Associate Professor 
School of Nursing 
University of Michigan 
Nurse Practitioner 
Packard Health 
Ann Arbor, Michigan 

Amanda Zimmerman, PA-C 
Physician Assistant 
West Forsyth Pain Management 
Winston-Salem, North Carolina 

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA. 

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE. 

Link to full program: https://bit.ly/44wOqkc

Listen as Amanda Zimmerman, PA-C, answers the most pressing questions from the first live webinar of the 2022-2023 Opioid REMS Education Initiative, “What All Practitioners Should Know About Mechanisms and Assessment of Pain.”

Presenter:

Amanda Zimmerman, PA-C
Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi
 

Listen as Vanila Singh, MD, MACM, speaks with Maggie Buckley, a woman with Ehlers-Danlos syndrome and chronic pain, about her experience with pain therapies and different healthcare professionals over the years. They have an enlightening discussion about the challenges both patients and healthcare professionals face in optimizing pain management, with a poignant conversation about how stigma plays a role in pain medicine. They close by offering advice to fellow healthcare professionals and patients on how to approach pain management from both perspectives.

Presenters:

Vanila Singh, MD, MACM

Clinical Associate Professor 
Department of Anesthesiology, Peri-operative, and Pain Medicine
Stanford School of Medicine
Palo Alto, California
Chairperson, Former Chief Medical Officer
HHS Pain Management Pain Task Force
US Department of Health and Human Services

Maggie Buckley  

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see

https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:

https://bit.ly/3mcDHsi

Listen as Vanila M. Singh, MD, MACM, and Theresa Mallick-Searle,MS, PMGT-BC, ANP-BC, provide thoughtful answers and clinical insights to audience questions that were submitted at a recent webinar about developing individualized pain treatment plans. Topics covered in this podcast include risk assessment, navigating the balance between “law enforcement” and “healthcare professional” when prescribing opioids, and prescription drug monitoring programs.

Presenters:

Vanila M. Singh, MD, MACM
Clinical Associate Professor
Stanford University School of Medicine
Palo Alto, California
FMR Chief Medical Officer
US Department of Health and Human Services
Chairperson
Congressionally Mandated Pain Task Force

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC
Adult Nurse Practitioner
Division Pain Medicine
Stanford Health Care
Redwood City, California

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi
 

Listen as Stefan Kertesz, MD, MSc, and Kate M. Nicholson, JD, provide unique healthcare professional and patient perspectives on opioid tapering in the setting of chronic pain management. Their conversation includes commentary on the impact of the 2016 and 2022 CDC guidelines for prescribing opioids for pain, the importance of informed consent, and the ongoing research regarding risks and consequences of opioid tapers.

Select links to resources related to the content of this podcast episode include:

• Assessing Reasons for Decreased Primary Care Access for Individuals on Prescribed Opioids: An Audit Study journals.lww.com/pain/Citation/2021/05000/Assessing_reasons_for_decreased_primary_care.11.aspx
• Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain ncbi.nlm.nih.gov/pmc/articles/PMC5876887
• Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy jamanetwork.com/journals/jamanetworkopen/fullarticle/2795159

Stefan G. Kertesz, MD, MSc
Professor of Medicine
Department of Medicine
Division of Preventive Medicine
UAB Heersink School of Medicine
Birmingham, Alabama  

Kate M. Nicholson, JD  

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see

https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi

Listen as Amanda Zimmerman, PA-C, and Chin Hwa (Gina) Dahlem, PhD, FNP-C, answer audience questions that were submitted at the June 2023 webinar titled, “Safe and Smart: Teaching Patients About Safe Opioid Practices.” Their answers cover topics including how to conduct a pill count and cost concerns regarding naloxone.

Presenters:

Chin Hwa (Gina) Dahlem, PhD, FNP-C
Clinical Associate Professor
School of Nursing
University of Michigan
Nurse Practitioner
Packard Health
Ann Arbor, Michigan

Amanda Zimmerman, PA-C
Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi

Listen as Stefan Kertesz, MD, MSc, and Kate M. Nicholson, JD, provide unique healthcare professional and patient perspectives on opioid tapering in the setting of chronic pain management. Their conversation includes commentary on the impact of the 2016 and 2022 CDC guidelines for prescribing opioids for pain, the importance of informed consent, and the ongoing research regarding risks and consequences of opioid tapers.

Select links to resources related to the content of this podcast episode include:

• Assessing Reasons for Decreased Primary Care Access for Individuals on Prescribed Opioids: An Audit Study

• journals.lww.com/pain/Citation/2021/05000/Assessing_reasons_for_decreased_primary_care.11.aspx

• Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain

• ncbi.nlm.nih.gov/pmc/articles/PMC5876887

• Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy

• jamanetwork.com/journals/jamanetworkopen/fullarticle/2795159

Presenters:

Stefan Kertesz, MD, MSc
Professor of Medicine
Department of Medicine
Division of Preventive Medicine
UAB Heersink School of Medicine
Birmingham, Alabama

Kate M. Nicholson, JD

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi

Listen as Vanila M. Singh, MD, MACM, and Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, provide thoughtful answers and clinical insights to audience questions that were submitted at a recent webinar about developing individualized pain treatment plans. Topics covered in this podcast include risk assessment, navigating the balance between “law enforcement” and “healthcare professional” when prescribing opioids, and prescription drug monitoring programs.

Presenters:

Vanila M. Singh, MD, MACM
Clinical Associate Professor
Stanford University School of Medicine
Palo Alto, California
FMR Chief Medical Officer
US Department of Health and Human Services
Chairperson
Congressionally Mandated Pain Task Force

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC
Adult Nurse Practitioner
Division Pain Medicine
Stanford Health Care
Redwood City, California

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://bit.ly/3mgrfb9 for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi